Central Texas TX

Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials

Brenham Banner Press

May 17, 2021

BOSTON, May 17, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercializatio…

Read the full story at Brenham Banner Press

Related places

Boston Brenham

Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials

Related places

More from Central Texas

Women's Golf in First after round one of the Golfweek October Classic

Mills County Judge's Report

Eagles lose edge Nolan Smith to concussion

FIELD GOAL TROUBLE CAUSES BLINN FOOTBALL TO LOSE TO CISCO IN 2-OT

Killeen ISD projects create new opportunities for Central Texas contractors

More than 600 turn out for Killeen NAACP's 15th annual breast cancer walk

CTC HVAC program sees record enrollment following instructional changes

Boil-order lifted for properties on Elms Road